<?xml version="1.0" encoding="UTF-8"?>
<!--generator='jetpack-15.9'-->
<!--Jetpack_Sitemap_Buffer_News_XMLWriter-->
<?xml-stylesheet type="text/xsl" href="//pharminent.com/news-sitemap.xsl"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.sitemaps.org/schemas/sitemap/0.9 http://www.sitemaps.org/schemas/sitemap/0.9/sitemap.xsd">
 <url>
  <loc>https://pharminent.com/82172-2/</loc>
  <lastmod>2026-06-19T19:33:41Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Pharminent</news:name>
    <news:language>en</news:language>
   </news:publication>
   <news:title></news:title>
   <news:publication_date>2026-06-19T19:33:38Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://pharminent.com/glp-1-competitive-market/glp-1-competitive-market-digest-weekly-june-19-2026/</loc>
  <lastmod>2026-06-19T19:21:12Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Pharminent</news:name>
    <news:language>en</news:language>
   </news:publication>
   <news:title>GLP-1 Competitive Market Digest • Weekly • June 19, 2026</news:title>
   <news:publication_date>2026-06-19T19:21:10Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://pharminent.com/82166-2/</loc>
  <lastmod>2026-06-19T18:53:17Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Pharminent</news:name>
    <news:language>en</news:language>
   </news:publication>
   <news:title></news:title>
   <news:publication_date>2026-06-19T18:53:15Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://pharminent.com/strategic-news-watch/strategic-news-watch-june-19-2026/</loc>
  <lastmod>2026-06-19T15:57:38Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Pharminent</news:name>
    <news:language>en</news:language>
   </news:publication>
   <news:title>Strategic News Watch • June 19, 2026</news:title>
   <news:publication_date>2026-06-19T15:57:36Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://pharminent.com/rare-disease-gene-therapy/rare-disease-gene-therapy-digest-june-18-2026/</loc>
  <lastmod>2026-06-19T13:25:17Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Pharminent</news:name>
    <news:language>en</news:language>
   </news:publication>
   <news:title>Rare Disease &amp;#038; Gene Therapy Digest • June 18, 2026</news:title>
   <news:publication_date>2026-06-19T13:25:15Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://pharminent.com/biogen-to-acquire-raythera-for-up-to-1bn/</loc>
  <lastmod>2026-06-19T15:02:16Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Pharminent</news:name>
    <news:language>en</news:language>
   </news:publication>
   <news:title>Biogen to acquire RayThera for up to $1bn</news:title>
   <news:publication_date>2026-06-19T09:23:13Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://pharminent.com/82113-2/</loc>
  <lastmod>2026-06-18T20:35:15Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Pharminent</news:name>
    <news:language>en</news:language>
   </news:publication>
   <news:title></news:title>
   <news:publication_date>2026-06-18T20:35:12Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://pharminent.com/moderna-flu-vaccine-wins-unanimous-support-from-fda-panel/</loc>
  <lastmod>2026-06-19T16:14:42Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Pharminent</news:name>
    <news:language>en</news:language>
   </news:publication>
   <news:title>Moderna flu vaccine wins unanimous support from FDA panel</news:title>
   <news:publication_date>2026-06-18T20:25:00Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://pharminent.com/82110-2/</loc>
  <lastmod>2026-06-18T20:04:45Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Pharminent</news:name>
    <news:language>en</news:language>
   </news:publication>
   <news:title></news:title>
   <news:publication_date>2026-06-18T20:04:42Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://pharminent.com/strategic-news-watch/strategic-news-watch-june-18-2026/</loc>
  <lastmod>2026-06-18T18:49:17Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Pharminent</news:name>
    <news:language>en</news:language>
   </news:publication>
   <news:title>Strategic News Watch • June 18, 2026</news:title>
   <news:publication_date>2026-06-18T18:49:15Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://pharminent.com/new-biotech-campfield-emerges-with-180m-to-reshape-ibd-treatment/</loc>
  <lastmod>2026-06-19T13:49:10Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Pharminent</news:name>
    <news:language>en</news:language>
   </news:publication>
   <news:title>New biotech cAMPfield emerges with $180M to reshape IBD treatment</news:title>
   <news:publication_date>2026-06-18T14:35:58Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://pharminent.com/heart-drug-biotech-kardigan-raises-400m-in-upscaled-ipo/</loc>
  <lastmod>2026-06-18T15:14:55Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Pharminent</news:name>
    <news:language>en</news:language>
   </news:publication>
   <news:title>Heart drug biotech Kardigan raises $400m in upscaled IPO</news:title>
   <news:publication_date>2026-06-18T13:13:09Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://pharminent.com/cardio-biotech-kardigan-binds-off-400m-upsized-ipo/</loc>
  <lastmod>2026-06-19T13:49:23Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Pharminent</news:name>
    <news:language>en</news:language>
   </news:publication>
   <news:title>Cardio biotech Kardigan binds off $400M upsized IPO</news:title>
   <news:publication_date>2026-06-18T13:10:00Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://pharminent.com/gsk-claims-fda-okay-for-first-oral-carbapenem-antibiotic/</loc>
  <lastmod>2026-06-19T14:00:49Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Pharminent</news:name>
    <news:language>en</news:language>
   </news:publication>
   <news:title>GSK claims FDA okay for first oral carbapenem antibiotic</news:title>
   <news:publication_date>2026-06-18T11:18:48Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://pharminent.com/lg-ai-research-and-dd-pharmatech-sign-agreement-for-oral-peptide-drugs/</loc>
  <lastmod>2026-06-19T13:52:03Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Pharminent</news:name>
    <news:language>en</news:language>
   </news:publication>
   <news:title>LG AI Research and D&amp;amp;D Pharmatech sign agreement for oral peptide drugs</news:title>
   <news:publication_date>2026-06-18T09:29:44Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
 <url>
  <loc>https://pharminent.com/biogen-pens-1bn-deal-to-buy-immunology-biotech-raythera/</loc>
  <lastmod>2026-06-18T15:15:06Z</lastmod>
  <news:news>
   <news:publication>
    <news:name>Pharminent</news:name>
    <news:language>en</news:language>
   </news:publication>
   <news:title>Biogen pens $1bn deal to buy immunology biotech RayThera</news:title>
   <news:publication_date>2026-06-18T08:58:53Z</news:publication_date>
   <news:genres>Blog</news:genres>
  </news:news>
 </url>
</urlset>
